Your browser doesn't support javascript.
loading
Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses.
Banaj, Nerisa; Vecchio, Daniela; Piras, Fabrizio; De Rossi, Pietro; Bustillo, Juan; Ciufolini, Simone; Dazzan, Paola; Di Forti, Marta; Dickie, Erin W; Ford, Judith M; Fuentes-Claramonte, Paola; Gruber, Oliver; Guerrero-Pedraza, Amalia; Hamilton, Holly K; Howells, Fleur M; Kraemer, Bernd; Lawrie, Stephen M; Mathalon, Daniel H; Murray, Robin; Pomarol-Clotet, Edith; Potkin, Steven G; Preda, Adrian; Radua, Joaquim; Richter, Anja; Salvador, Raymond; Sawa, Akira; Scheffler, Freda; Sim, Kang; Spaniel, Filip; Stein, Dan J; Temmingh, Henk S; Thomopoulos, Sophia I; Tomecek, David; Uhlmann, Anne; Voineskos, Aristotle; Yang, Kun; Jahanshad, Neda; Thompson, Paul M; Van Erp, Theo G M; Turner, Jessica A; Spalletta, Gianfranco; Piras, Federica.
Afiliação
  • Banaj N; Neuropsychiatry Laboratory, Department of Clinical Neuroscience and Neurorehabilitation, IRCCS Santa Lucia Foundation, Rome, Italy. n.banaj@hsantalucia.it.
  • Vecchio D; Neuropsychiatry Laboratory, Department of Clinical Neuroscience and Neurorehabilitation, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Piras F; Neuropsychiatry Laboratory, Department of Clinical Neuroscience and Neurorehabilitation, IRCCS Santa Lucia Foundation, Rome, Italy.
  • De Rossi P; Child and Adolescence Neuropsychiatry Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Bustillo J; Psichiatry and Neuroscience, University of New Mexico, Albuquerque, NM, USA.
  • Ciufolini S; Psychosis Studies, Institute of Psychiatry, Psychology and Neurology, King's College London, London, UK.
  • Dazzan P; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neurology, King's College London, London, UK.
  • Di Forti M; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neurology, King's College London, London, UK.
  • Dickie EW; Center for Addiction and Mental Health, Campbell Family Mental Health Research Institute, Toronto, ON, Canada.
  • Ford JM; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Fuentes-Claramonte P; Kimel Family Lab, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Gruber O; San Francisco VA Health Care System, San Francisco, CA, USA.
  • Guerrero-Pedraza A; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA.
  • Hamilton HK; FIMDAG Sisters Hospitallers Research Foundation, Barcelona, Spain.
  • Howells FM; Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
  • Kraemer B; Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Baden-Wuerttemberg, Germany.
  • Lawrie SM; Hospital Benito Menni CASM, Barcelona, Spain.
  • Mathalon DH; San Francisco VA Health Care System, San Francisco, CA, USA.
  • Murray R; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA.
  • Pomarol-Clotet E; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, Western Cape, South Africa.
  • Potkin SG; Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Baden-Wuerttemberg, Germany.
  • Preda A; Division of Psychiatry, University of Edinburgh, Edinburg, EH10 5HF, UK.
  • Radua J; San Francisco VA Health Care System, San Francisco, CA, USA.
  • Richter A; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA.
  • Salvador R; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neurology, King's College London, London, UK.
  • Sawa A; FIMDAG Sisters Hospitallers Research Foundation, Barcelona, Spain.
  • Scheffler F; Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
  • Sim K; Department of Psychiatry, University of California Irvine, Newfoundland, NJ, NJ 07435, USA.
  • Spaniel F; Psychiatry and Human Behavior, University of California Irvine, Orange, CA, 92868, USA.
  • Stein DJ; Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
  • Temmingh HS; Imaging of mood- and anxiety-related disorders (IMARD), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain.
  • Thomopoulos SI; Medicina, University of Barcelona, Barcelona, 08036, Spain.
  • Tomecek D; Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Baden-Wuerttemberg, Germany.
  • Uhlmann A; FIMDAG Sisters Hospitallers Research Foundation, Barcelona, Spain.
  • Voineskos A; Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Yang K; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Jahanshad N; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Thompson PM; Department of Genetic Medicine, Johns Hopkins University School of Medicine Baltimore, Baltimore, MD, USA.
  • Van Erp TGM; Department of Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Turner JA; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Spalletta G; Department of Psychiatry and Mental Health, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
  • Piras F; Brain Behavior Unit, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
Mol Psychiatry ; 28(10): 4363-4373, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37644174
ABSTRACT
Converging evidence suggests that schizophrenia (SZ) with primary, enduring negative symptoms (i.e., Deficit SZ (DSZ)) represents a distinct entity within the SZ spectrum while the neurobiological underpinnings remain undetermined. In the largest dataset of DSZ and Non-Deficit (NDSZ), we conducted a meta-analysis of data from 1560 individuals (168 DSZ, 373 NDSZ, 1019 Healthy Controls (HC)) and a mega-analysis of a subsampled data from 944 individuals (115 DSZ, 254 NDSZ, 575 HC) collected across 9 worldwide research centers of the ENIGMA SZ Working Group (8 in the mega-analysis), to clarify whether they differ in terms of cortical morphology. In the meta-analysis, sites computed effect sizes for differences in cortical thickness and surface area between SZ and control groups using a harmonized pipeline. In the mega-analysis, cortical values of individuals with schizophrenia and control participants were analyzed across sites using mixed-model ANCOVAs. The meta-analysis of cortical thickness showed a converging pattern of widespread thinner cortex in fronto-parietal regions of the left hemisphere in both DSZ and NDSZ, when compared to HC. However, DSZ have more pronounced thickness abnormalities than NDSZ, mostly involving the right fronto-parietal cortices. As for surface area, NDSZ showed differences in fronto-parietal-temporo-occipital cortices as compared to HC, and in temporo-occipital cortices as compared to DSZ. Although DSZ and NDSZ show widespread overlapping regions of thinner cortex as compared to HC, cortical thinning seems to better typify DSZ, being more extensive and bilateral, while surface area alterations are more evident in NDSZ. Our findings demonstrate for the first time that DSZ and NDSZ are characterized by different neuroimaging phenotypes, supporting a nosological distinction between DSZ and NDSZ and point toward the separate disease hypothesis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália